Revelation Biosciences, Inc. (REVB)
1.01
0.00 (0.00%)
USD |
NASDAQ |
Sep 09, 13:06
Revelation Biosciences EPS Diluted (Quarterly) : -0.8679 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.8679 |
| March 31, 2026 | -2.709 |
| December 31, 2025 | -1.648 |
| September 30, 2025 | -7.074 |
| June 30, 2025 | -28.04 |
| March 31, 2025 | -2.112 |
| December 31, 2024 | -59.76 |
| September 30, 2024 | -0.8364 |
| June 30, 2024 | -5.131 |
| March 31, 2024 | -2.460 |
| December 31, 2023 | -8.327 |
| September 30, 2023 | -12.52 |
| June 30, 2023 | -7.475 |
| March 31, 2023 | 58.92 |
| Date | Value |
|---|---|
| December 31, 2022 | -53.05 |
| September 30, 2022 | -58.38 |
| June 30, 2022 | -127.72 |
| March 31, 2022 | -489.18 |
| December 31, 2021 | -78837.70 |
| September 30, 2021 | -97552.22 |
| June 30, 2021 | -79132.03 |
| March 31, 2021 | -83724.48 |
| December 31, 2020 | -187.19 |
| September 30, 2020 | -0.0945 |
| June 30, 2020 | -0.0315 |
| March 31, 2020 | -2.720 |
| December 31, 2019 | -0.42 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Shuttle Pharmaceuticals Holdings, Inc. | -4.278 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Agenus, Inc. | -0.0146 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Amgen, Inc. | 4.366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.323M |
| Total Expenses (Quarterly) | 3.323M |
| Enterprise Value | -6.795M |
| Earnings Yield | -1.22K% |
| Normalized Earnings Yield | -1217.72 |